Literature DB >> 35462664

Management of Primary Hyperparathyroidism.

Murad Lala1.   

Abstract

Primary hyperparathyroidism (PHPT) is the unregulated overproduction of parathyroid hormone (PTH) resulting in abnormal calcium homeostasis. The disease profile has evolved over the last century from symptomatic hyperparathyroidism to asymptomatic hyperparathyroidism. Primary hyperparathyroidism is a biochemical diagnosis. Parathyroidectomy is the only established cure for this disease. Every effort is made to localize the offending gland preoperaively with various imaging modalities. These localization studies along with intraoperative parathormone monitoring will direct the surgeon to either a focused parathyroidectomy or a four gland exploration. All symptomatic patients and asymptomatic patients who meet the criteria for surgery should undergo parathyroidectomy if no medical contraindications exist. Pharmacologic approaches are reserved for those patients unfit or unwilling to undergo surgery. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Diagnosis; Epidemiology; Hyperparathyroidism; Medical management; Parathyroidectomy; Preoperative imaging; Primary

Year:  2021        PMID: 35462664      PMCID: PMC8986895          DOI: 10.1007/s13193-021-01319-3

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  40 in total

1.  Reoperative parathyroid surgery: the importance of ectopic location and multigland disease.

Authors:  Ian Gough
Journal:  ANZ J Surg       Date:  2006-12       Impact factor: 1.872

2.  Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma.

Authors:  Angelica M Silva-Figueroa; Kenneth R Hess; Michelle D Williams; Callisia N Clarke; Ioannis Christakis; Paul H Graham; Elizabeth G Grubbs; Jeffrey E Lee; Naifa L Busaidy; Nancy D Perrier
Journal:  J Am Coll Surg       Date:  2017-03-15       Impact factor: 6.113

3.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

4.  Dose-response relationships for radiation-induced hyperparathyroidism.

Authors:  A B Schneider; T C Gierlowski; E Shore-Freedman; M Stovall; E Ron; J Lubin
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

5.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

6.  Scintigraphic findings in hungry bone syndrome following parathyroidectomy.

Authors:  S Ajmi; R Sfar; S Trimeche; K Ben Ali; M Nouira
Journal:  Rev Esp Med Nucl       Date:  2009-12-05

7.  Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy.

Authors:  S Tezelman; W Shen; J K Shaver; A E Siperstein; Q Y Duh; H Klein; O H Clark
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

8.  Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.

Authors:  Elizabeth A Mittendorf; James I Merlino; Christopher R McHenry
Journal:  Am Surg       Date:  2004-02       Impact factor: 0.688

9.  Vocal cord paralysis and reoperative parathyroidectomy. A prospective study.

Authors:  C A Patow; J A Norton; M F Brennan
Journal:  Ann Surg       Date:  1986-03       Impact factor: 12.969

10.  Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease.

Authors:  Sanjay Kumar Yadav; Goonj Johri; Raouef Ahmed Bichoo; Chandan Kumar Jha; Ronald Kintu-Luwaga; Saroj Kanta Mishra
Journal:  Arch Endocrinol Metab       Date:  2020-03-27       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.